AMP has always been slow on the uptake but this time they have got it right. I don't believe that they will stop at just 5%.
Expect other Institutions to follow.
VSL is an asset play in that the sum of the parts is worth very much more than the whole.
My valuation is between $1.70 and $2.10.
Dr Fox could their be a move to unload VisionBio to its main US competitor which last time I looked traded at about 60 times earnings.
